Since these changes of the glioma tumors at the gene level were identical with the results observed at their protein levels, it is reasonable to consider that CREB3L1 and PTN serve as biomarkers for helping to identify the nature of the glial cells and evaluating malignant degrees of brain gliomas. Here, CREB3L1 is linked to brain glioma.